34 results on '"Fehse B"'
Search Results
2. Digital-PCR assay for screening and quantitative monitoring of calreticulin (CALR) type-2 positive patients with myelofibrosis following allogeneic stem cell transplantation
3. Donor choice in haploidentical stem cell transplantation: fetal microchimerism is associated with better outcome in pediatric leukemia patients
4. ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN HIV-POSITIVE PATIENTS WITH HIGH-RISK HEMATOLOGIC MALIGNANCIES: PH-AB265
5. Introduction of differential KIR activation mediated patterns of NK cell cytotoxicity against myeloma: P884
6. Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCT
7. Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44+) and T (HLA-DR+) cells
8. Influence of mannose-binding lectin genotypes and serostatus in allo-SCT: analysis of 131 recipients and donors
9. Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma: O157
10. Minimal residual disease diagnostics in myeloid malignancies in the post transplant period
11. Transportation and cryopreservation may impair haematopoietic stem cell function and engraftment of allogeneic PBSCs, but not BM
12. Monitoring of minimal residual disease in multiple myeloma after allo-SCT: flow cytometry vs PCR-based techniques
13. The priority of lymphoid reconstitution as a prognostic factor for the results of unrelated haematopoietic stem cell transplantation for different haematological malignancies
14. Retroviral vector insertions in T-lymphocytes used for suicide gene therapy occur in gene groups with specific molecular functions
15. Mesenchymal stem cells are able to stimulate alloreactive immune cells
16. Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up
17. Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants
18. Measuring aldehyde dehydrogenase activity for quality assessment of haematopoietic stem cell transplants
19. Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma
20. Pilot study of reduced-intensity conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with myelofibrosis
21. Induction of molecular remission by donor lymphocyte infusions in patients with multiple myeloma and residual disease after dose-reduced conditioning and allogeneic stem cell transplantation
22. Hyperactive alleles of the non-cytokine genes may affect clinical outcomes in allo-HSCT patients
23. Similar outcome of calreticulin type I and calreticulin type II mutations following RIC allogeneic haematopoietic stem cell transplantation for myelofibrosis
24. Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44+) and T (HLA-DR+) cells
25. Influence of mannose-binding lectin genotypes and serostatus in allo-SCT: analysis of 131 recipients and donors
26. Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up
27. Depletion of alloreactive donor T cells using immunomagnetic cell selection
28. Amphotropic and VSV-G-pseudotyped retroviral vectors transduce human hematopoietic progenitor cells with similar efficiency
29. Retroviral transduction of T lymphocytes for suicide gene therapy in allogeneic stem cell transplantation
30. Purging and haemopoietic progenitor cell selection by CD34+ cell separation
31. Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44+) and T (HLA-DR+) cells.
32. Purging and haemopoietic progenitor cell selection by CD34+ cell separation.
33. Spleen volume and length determined by computed tomography impact outcome after allogeneic stem cell transplantation for myelofibrosis.
34. Digital-droplet PCR assays for IDH, DNMT3A and driver mutations to monitor after allogeneic stem cell transplantation minimal residual disease of myelofibrosis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.